Aldose reductase inhibitors and uses thereof

A technology of uses and compounds, applied in the fields of organic chemistry, drug combination, cardiovascular system diseases, etc., can solve the problems of excess sorbitol and difficult diffusion.

Active Publication Date: 2016-03-23
THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This results in an excess of sorbitol in the cell, which does not readily diffuse through cell membranes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aldose reductase inhibitors and uses thereof
  • Aldose reductase inhibitors and uses thereof
  • Aldose reductase inhibitors and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0252] Example 1: Preparation of Compound A.

[0253] Compound A was prepared as illustrated schematically below.

[0254]

[0255] Preparation of (E) / (Z)-2-(7-oxofuro[3,4-b]pyrazine-5(7H)-ylidene) tert-butyl acetate (compound 1)

[0256] To stirred 5.05 g (33.63 mmol) of commercially available 2,3-pyrazine dicarboxylic anhydride in 300 mL CHCl 3 12.34 g (33.63 mmol) (tert-butoxycarbonylmethylene)-triphenylphosphorane were added to the solution. The resulting solution was heated to 62 °C for 2 days. The reaction mixture was concentrated in vacuo, and the residue was purified by flash column chromatography on silica gel (monitored by thin layer chromatography) and eluted with 1:1 (v / v) hexane:ethyl acetate. Evaporation of the collected fractions yielded 2.99 g (36% yield) of (E) / (Z)-2-(7-oxofurano as a mixture (~1:1) of unresolved geometric isomers [3,4-b]pyrazine-5(7H)-ylidene) tert-butyl acetate (compound 1): 1 HNMR (CDCl 3 ,300MHz):δ ppm 9.03(d,J=2.4Hz,1H),8.96(d,J...

Embodiment 2

[0263] Example 2: Alternative Preparation of Compound A.

[0264]

[0265] Preparation of 2-(iodomethyl)-5-(trifluoromethyl)benzo[d]thiazole (compound 5)

[0266] To a stirred solution of 10.79 g (42.97 mmol) of 2-(chloromethyl)-5-(trifluoromethyl)benzo[d]thiazole (compound 3) in 86 mL of acetone was added 7.40 g (49.42 mmol) of sodium iodide . The resulting reaction mixture was heated to 55 °C for 1 hour. The reaction mixture was cooled to ambient temperature and concentrated under vacuum. The residue was partitioned between EtOAc and water, the layers were separated, and the organic layer was washed with water (1x). The recovered organic layer was then washed with 1.0M Na 2 S 2 o 3 Process and stir vigorously for 15 minutes. The layers were then separated and the organic layer was washed sequentially with water (1x) and brine (1x). The organic layer was washed with Na 2 SO 4 Dried, filtered and concentrated under vacuum to yield 14.28 g (97% crude yield) of 2-(i...

Embodiment 3

[0278] Example 3: Preparation of Compound 8.

[0279] Compound 8 shown below was prepared as follows:

[0280]

[0281] Except that 5-chloro-2-(chloromethyl)-benzo[d]thiazole was the reagent used instead of 2-(chloromethyl)-5-(trifluoromethyl)benzo[d]thiazole, The preparation described for compound 4 was repeated using the same molar ratios as previously described. In this case, the final product obtained was 2-(7-((5-chlorobenzo[d]thiazol-2-yl)methyl)-8-oxo-7,8-di Hydropyrazino[2,3-d]pyridazin-5-yl) tert-butyl acetate (compound 8): 1 HNMR (CDCl 3 ,300MHz): δ ppm 9.08(s,1H),9.05(s,1H),8.00(s,1H),7.74(d,J=8.7Hz,1H),7.36(d,J=8.7Hz,1H),5.87(s,2H ), 4.04(s,2H), 1.41(s,9H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to novel compounds and pharmaceutical compositions thereof, and the use of compounds and compositions of the present invention to promote healthy aging of the skin, to treat skin disorders, to treat cardiovascular disorders, to treat renal disorders, to treat angiogenic disorders such as cancer, to treat tissue Injuries such as non-cardiac tissue injuries, methods of treating developing myocardial infarction and treating various other conditions such as complications due to diabetes. Other conditions may include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, skin infection, peripheral vascular disease, stroke, and the like.

Description

[0001] This application claims the benefit of priority to US Provisional Patent Application No. 61 / 365,098, filed July 16, 2010, the entire disclosure of which is hereby incorporated by reference. [0002] All patents, patent applications, and publications cited herein are hereby incorporated by reference in their entirety. The disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art as known to those skilled in these publications as of the date of the invention described and claimed herein. [0003] This patent disclosure contains material that is protected by copyright. The copyright owner has no objection to the reproduction by anyone of the patent document or patent disclosure as it appears in the US Patent and Trademark Office patent file or files, but otherwise reserves any and all copyright rights therein. field of invention [0004] The present invention relates to nove...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/00
CPCC07D487/04A61P3/10A61P17/00A61P35/00
Inventor A·沃斯穆特D·W·兰德瑞S·X·邓R·拉马萨米A·M·施米德B·L·米拉瑞
Owner THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap